2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic …

L Mazzolai, G Teixido-Tura, S Lanzi, V Boc… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

[HTML][HTML] Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022

ОМ Драпкина, АВ Концевая, АМ Калинина… - Кардиоваскулярная …, 2022 - cyberleninka.ru
Члены Комитета экспертов подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Комитета …

Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: A tailored diagnosis and treatment …

G Mahé, V Aboyans, E Cosson, K Mohammedi… - Cardiovascular …, 2024 - Springer
Lower extremity peripheral artery disease (PAD) often results from atherosclerosis, and is
highly prevalent in patients with type 2 diabetes mellitus (T2DM). Individuals with T2DM …

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

M Valgimigli, V Aboyans, D Angiolillo… - European Heart …, 2023 - academic.oup.com
Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …

[HTML][HTML] Editor's Choice–PRINciples of optimal antithrombotiC therapy and coagulation managEment during elective fenestrated and branched EndovaScular aortic …

M D'Oria, L Bertoglio, AA Bignamini, K Mani… - European Journal of …, 2022 - Elsevier
Objective Management of antithrombotic therapy in patients undergoing elective fenestrated
branched endovascular aortic repair (F-BEVAR) is not standardised, nor are there any …

Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The …

KAA Fox, V Aboyans, ES Debus… - European Heart …, 2022 - academic.oup.com
Aims To determine the characteristics of patients with coronary artery disease (CAD),
peripheral artery disease (PAD), or both, initiating dual pathway inhibition (DPI) using …

Focus on the most common paucisymptomatic vasculopathic population, from diagnosis to secondary prevention of complications

E Martelli, I Enea, M Zamboni, M Federici, UM Bracale… - Diagnostics, 2023 - mdpi.com
Middle-aged adults can start to be affected by some arterial diseases (ADs), such as
abdominal aortic or popliteal artery aneurysms, lower extremity arterial disease, internal …

Correlation between coronary artery disease with other arterial systems: similar, albeit separate, underlying pathophysiologic mechanisms

A Achim, OÁ Péter, M Cocoi, A Serban, S Mot… - Journal of …, 2023 - mdpi.com
Atherosclerosis is a multifactorial systemic disease that affects the entire arterial tree,
although some areas are more prone to lipid deposits than others. Moreover, the …

Antithrombotic therapy in peripheral artery disease: current evidence and future directions

ME Canonico, R Piccolo, M Avvedimento… - Journal of …, 2023 - mdpi.com
Patients with peripheral artery disease (PAD) are at an increased risk of major adverse
cardiovascular events, and those with disease in the lower extremities are at risk of major …

Antiplatelet therapy in patients with abdominal aortic aneurysm without symptomatic atherosclerotic disease

CW Nicolajsen, M Søgaard, M Jensen… - JAMA network …, 2023 - jamanetwork.com
Importance Patients with abdominal aortic aneurysm have a high risk of ischemic events
associated with concomitant atherosclerotic cardiovascular disease, and current clinical …